Las Vegas, NV -- (SBWIRE) -- 12/30/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at Generex Biotechnology Corporation (OTCMKTS:GNBT), NII Holdings Inc (NASDAQ:NIHD), JPMorgan Chase & Co. (NYSE:JPM), Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX)
Generex Biotechnology Corporation (OTCMKTS:GNBT) was a volume gainer of 1.53 million shares and the average volume of the stock remained 1.82 million shares. The stock opened the session at $0.03 and finished at the end of the day at $0.0290.The market capitalization of the stock remained 16.83 million. The half-yearly trend of the stock remained negative -10.77%. Generex Biotechnology Corporation is a Canada-based Company, which develops drug delivery systems and technologies for the treatment of diabetes. The Company has developed a proprietary platform technology for the delivery of drugs into the human body through the oral cavity. Its buccal insulin spray product, Generex Oral-lyn is in Phase III clinical trials at several sites around the world.
Is GNBT a Solid Investment at These Levels? Read This Report For Details
In the preceding trading session, NII Holdings Inc (NASDAQ:NIHD) exchanged 2.39 million shares and the average volume remained 5.98 million shares. The stock closed the session at $2.58 with the drop of -1.15%. Tracking three months and 6 months trends, the stock was at of -57.91% and -61.26%, respectively. NII Holdings, Inc. (NII Holdings) is a holding company for the operations of Nextel Communications, Inc. in selected International markets. The Company provides wireless communication services under the Nextel brand. It provides its services through operating companies located in Brazil, Mexico, Argentina, Peru and Chile, with its principal operations located in business centers and related transportation corridors of these countries.
Will NIHD Bounce Back After yesterday’s Sharp Sell off? Find Out Here
JPMorgan Chase & Co. (NYSE:JPM) decreased -0.10% and its closing price was $58.14. The volume of the stock was 8.94 million shares and the average volume remained 16.81 million shares. The stock traded amid the day price range of $58.06 - $58.35. The market capitalization of the stock remained 218.56 billion. The beta of the stock remained 1.68. JPMorgan Chase & Co. (JPMorgan Chase) is a financial holding company. The Company is a global financial services firm and a banking institution in the United States, with global operations. The Company is engaged in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, asset management and private equity.
Is it the Right to Grab JPM after the Recent Slump? Get Free Trend Analysis Here
Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) exchanged 1.51 million shares in the previous trading session, and its average trading remained 1.15 million shares. CPRX dropped -4.11% and it closed the trading at $2.10. The market capitalization of the stock remained 113.68 million. YTD trend of the stock was positive 382.76%. Catalyst Pharmaceutical Partners, Inc. is a development-stage biopharmaceutical company. The Company is focused on the development and commercialization of prescription drugs targeting addiction diseases and disorders of the central nervous system with a focus on the treatment of addiction and epilepsy.
Will CPRX Reach the Bottom after Yesterday’s Correction? Find Out Here
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)